These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 16146646)
1. Self-referential tags in the discourse of people with Alzheimer's disease. Asp E; Song X; Rockwood K Brain Lang; 2006 Apr; 97(1):41-52. PubMed ID: 16146646 [TBL] [Abstract][Full Text] [Related]
2. Verbal repetition in patients with Alzheimer's disease who receive donepezil. Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290 [TBL] [Abstract][Full Text] [Related]
5. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting. Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065 [TBL] [Abstract][Full Text] [Related]
6. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H; Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958 [TBL] [Abstract][Full Text] [Related]
7. Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months. Rockwood K; Dai D; Mitnitski A Int J Geriatr Psychiatry; 2008 Feb; 23(2):207-14. PubMed ID: 17621382 [TBL] [Abstract][Full Text] [Related]
8. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)]. Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995 [TBL] [Abstract][Full Text] [Related]
9. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis. Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings. Crowell TA; Paramadevan J; Abdullah L; Mullan M J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754 [TBL] [Abstract][Full Text] [Related]
11. Stress and coping in older people with Alzheimer's disease. de Souza-Talarico JN; Chaves EC; Nitrini R; Caramelli P J Clin Nurs; 2009 Feb; 18(3):457-65. PubMed ID: 19077019 [TBL] [Abstract][Full Text] [Related]
12. A neuropsychological test battery for use in Alzheimer disease clinical trials. Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy. Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434 [TBL] [Abstract][Full Text] [Related]
14. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]
15. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484 [TBL] [Abstract][Full Text] [Related]
16. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease. Bartorelli L; Giraldi C; Saccardo M; Cammarata S; Bottini G; Fasanaro AM; Trequattrini A; Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702 [TBL] [Abstract][Full Text] [Related]